文献速递心脏核医学肿瘤 PET/CT

淀粉样蛋白PET显像诊断心脏淀粉样变的系统评价与Meta分析

Cardiac amyloidosis imaging with amyloid positron emission tomography: A systematic review and meta-analysis.
PubMed 文献 · J Nucl Cardiol · 2018-07-18

该系统评价与Meta分析纳入6项研究共98例受试者,评估淀粉样蛋白PET诊断心脏淀粉样变的效能。汇总灵敏度0.95、特异度0.98、阳性似然比10.130、阴性似然比0.1、诊断比值比148.83。半定量参数在心脏淀粉样变患者中显著高于对照组(汇总SMD=1.42,P<.001),在AL型中显著高于ATTR型(汇总SMD=0.96,P<.001)。

要点

  • 淀粉样蛋白PET诊断心脏淀粉样变汇总灵敏度0.95、特异度0.98。
  • 半定量参数可辅助诊断心脏淀粉样变(汇总SMD=1.42,P<.001)。
  • 半定量参数有助于区分AL型与ATTR型(汇总SMD=0.96,P<.001)。

核心结论

  • 淀粉样蛋白PET显像可作为诊断心脏淀粉样变的有用方法。
  • 淀粉样蛋白PET的半定量参数有助于诊断心脏淀粉样变并辨别其类型。

研究设计与样本

  • 系统评价与Meta分析,系统检索关键词为心脏淀粉样变、淀粉样蛋白和PET。
  • 共纳入6项符合条件的研究,合计98例受试者。

主要发现

  • 汇总灵敏度为0.95,汇总特异度为0.98。
  • 汇总阳性似然比为10.130,汇总阴性似然比为0.1,汇总诊断比值比为148.83。
  • 心脏淀粉样变患者的淀粉样蛋白PET半定量参数显著高于对照组(汇总SMD=1.42;P<.001)。
  • AL型患者的半定量参数显著高于ATTR型(汇总SMD=0.96;P<.001)。

关键数值与推荐

  • 汇总灵敏度0.95、特异度0.98、阳性似然比10.130、阴性似然比0.1、诊断比值比148.83。
  • 心脏淀粉样变 vs 对照组半定量参数汇总SMD=1.42(P<.001)。
  • AL型 vs ATTR型半定量参数汇总SMD=0.96(P<.001)。

临床怎么用

  • 原文结论认为淀粉样蛋白PET显像可作为诊断心脏淀粉样变的有用方法。
  • 原文结论认为淀粉样蛋白PET的半定量参数有助于诊断心脏淀粉样变并辨别其类型。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent progress in amyloid positron emission tomography (PET) has enabled the targeted imaging of cardiac amyloidosis with accuracy. We performed a systematic review and meta-analysis on the diagnostic performance of cardiac amyloidosis using amyloid PET. METHODS: A systematic search was performed using key words: cardiac amyloidosis, amyloid, and PET. We estimated the pooled sensitivity, specificity, positive and negative likelihood ratio (LR), and diagnostic odds ratio (DOR). Furthermore, the semiquantitative parameters of PET were evaluated to diagnose cardiac amyloidosis and discern its type [systemic light chain amyloidosis (AL) vs transthyretin amyloidosis (ATTR)] using the pooled standardized mean difference (SMD). RESULTS: In total, six eligible studies with a total of 98 subjects were included in this meta-analysis. The pooled sensitivity was 0.95, the specificity was 0.98, positive LR was 10.130, negative LR was 0.1, and DOR was 148.83. The semiquantitative parameters of amyloid PET showed significantly higher values for cardiac amyloidosis patients than those for controls (pooled SMD = 1.42; P < .001), and in AL than ATTR (pooled SMD = 0.96; P < .001). CONCLUSION: Amyloid PET imaging can be a useful method for diagnosing cardiac amyloidosis. The semiquantitative parameters of amyloid PET can help diagnose cardiac amyloidosis and discern its type.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Kim YJ, Ha S, Kim YI, et al. Cardiac amyloidosis imaging with amyloid positron emission tomography: A systematic review and meta-analysis. J Nucl Cardiol. 2018. PMID: 30022405. doi:10.1007/s12350-018-1365-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。